Found: 28
Select item for more details and to access through your institution.
Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways.
- Published in:
- Nature Medicine, 2012, v. 18, n. 12, p. 1778, doi. 10.1038/nm.2984
- By:
- Publication type:
- Article
Host-reactive CD8<sup>+</sup> memory stem cells in graft-versus-host disease.
- Published in:
- Nature Medicine, 2005, v. 11, n. 12, p. 1299, doi. 10.1038/nm1326
- By:
- Publication type:
- Article
JAK2 V617F‐positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 1, p. 78, doi. 10.1111/bjh.15276
- By:
- Publication type:
- Article
Open-label study of oral CEP-701 (lestaurtinib) in patients with polycythaemia vera or essential thrombocythaemia with JAK2-V617F mutation.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 1, p. 83, doi. 10.1111/bjh.12607
- By:
- Publication type:
- Article
One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 802, doi. 10.1177/10781552231189199
- By:
- Publication type:
- Article
Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplant.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 892, doi. 10.1177/10781552221080710
- By:
- Publication type:
- Article
Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibition.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 4, p. 657, doi. 10.1007/s10637-018-0585-x
- By:
- Publication type:
- Article
Real‐world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 8, p. 1254, doi. 10.1002/ajh.26991
- By:
- Publication type:
- Article
Salvage therapy with basiliximab and etanercept for severe steroid‐refractory acute graft‐versus‐host disease.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. E273, doi. 10.1002/ajh.26568
- By:
- Publication type:
- Article
Pediatric chronic myeloid leukemia with inv(3)(q21q26.2) and T lymphoblastic transformation: a case report.
- Published in:
- Biomarker Research, 2016, v. 4, p. 1, doi. 10.1186/s40364-016-0069-0
- By:
- Publication type:
- Article
Targeted Signal Transduction Therapies in Myeloid Malignancies.
- Published in:
- Current Oncology Reports, 2010, v. 12, n. 6, p. 358, doi. 10.1007/s11912-010-0126-z
- By:
- Publication type:
- Article
4443 Tailoring Professional Development to CTS Trainees.
- Published in:
- 2020
- By:
- Publication type:
- Abstract
Graft-versus-host disease depletes plasmacytoid dendritic cell progenitors to impair tolerance induction.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Persistent Mixed Donor Chimerism following Double Umbilical Cord Transplantation in a Patient with T-Cell Prolymphocytic Leukemia.
- Published in:
- Case Reports in Hematology, 2019, p. 1, doi. 10.1155/2019/8437805
- By:
- Publication type:
- Article
Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 12, p. 2003, doi. 10.1093/cid/ciy822
- By:
- Publication type:
- Article
Molecular-Based Classification of Acute Myeloid Leukemia and Its Role in Directing Rational Therapy.
- Published in:
- Molecular Diagnosis & Therapy, 2012, v. 16, n. 6, p. 357, doi. 10.1007/s40291-012-0009-0
- By:
- Publication type:
- Article
Risk of invasive fungal infections in patients with high‐risk MDS and AML receiving hypomethylating agents.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 7, p. 792, doi. 10.1002/ajh.25808
- By:
- Publication type:
- Article
Multicenter analysis of the use of transjugular intrahepatic portosystemic shunt for management of MPN-associated portal hypertension.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. 909, doi. 10.1002/ajh.24798
- By:
- Publication type:
- Article
Unrelated donors are associated with improved relapse-free survival compared to related donors in patients with myelodysplastic syndrome undergoing reduced intensity allogeneic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 9, p. 883, doi. 10.1002/ajh.24424
- By:
- Publication type:
- Article
Time to unrelated donor leukocyte infusion is longer, but incidence of GVHD and overall survival are similar for recipients of unrelated DLI compared to matched sibling DLI.
- Published in:
- American Journal of Hematology, 2016, v. 91, p. 426, doi. 10.1002/ajh.24308
- By:
- Publication type:
- Article
Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftment.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 5, p. 453, doi. 10.1002/ajh.24303
- By:
- Publication type:
- Article
Time to unrelated donor leukocyte infusion is longer, but incidence of GVHD and overall survival are similar for recipients of unrelated DLI compared to matched sibling DLI.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 4, p. 426, doi. 10.1002/ajh.24308
- By:
- Publication type:
- Article
Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 8, p. 657, doi. 10.1002/ajh.23468
- By:
- Publication type:
- Article
Trisomy 8 in an allogeneic stem cell transplant recipient representative of a donor-derived constitutional abnormality.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 11, p. 846, doi. 10.1002/ajh.21268
- By:
- Publication type:
- Article
Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial.
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0417-z
- By:
- Publication type:
- Article
The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosis.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 4, p. 508, doi. 10.1111/bjh.12274
- By:
- Publication type:
- Article
Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00487-x
- By:
- Publication type:
- Article
Hodgkin lymphoma patients have an increased incidence of idiopathic acquired aplastic anemia.
- Published in:
- PLoS ONE, 2019, v. 14, n. 4, p. 1, doi. 10.1371/journal.pone.0215021
- By:
- Publication type:
- Article